Key result
PCI carries a ~7% risk of periprocedural MI, linked to adverse clinical outcomes.
Why the study?
Periprocedural myocardial infarction occurs in about 6 – 7% of patients undergoing PCI and is associated with adverse outcomes, making it important to identify factors to detect, prevent, and manage this event.
Answers are grounded in this paper and cite their sources.
Periprocedural myocardial infarction complicates 6–7% of percutaneous coronary interventions and is linked to adverse clinical outcomes, highlighting the need for targeted detection, prevention, and management strategies.
Percutaneous coronary intervention can be associated with several complications such as periprocedural myocardial infarction (PPMI) that was defined as an elevation of CK-MB >3 times the upper limit of the normal range in at least two blood samples with a normal range of baseline value, prolonged ischemia as demonstrated by persistent chest pain (>20 min), or new pathological Q waves seen on the electrocardiogram. By epidemiology, periprocedural myocardial infarction was happen in about 6 – 7% patient underwent PCI and associated with adverse outcome. Therefore it is important to identify the possible factors to detect, prevent and manage this event.
No takes yet. Share an insight, caveat, or question.
Pratiwi et al. (2022) conducted a review in Periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. Percutaneous coronary intervention (PCI) was evaluated on Periprocedural myocardial infarction (elevation of CK-MB >3 times ULN in at least two samples, prolonged ischemia >20 min, or new pathological Q waves). Percutaneous coronary intervention is complicated by periprocedural myocardial infarction in approximately 6-7% of patients and is associated with adverse outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: